新生儿肺透明膜病的替代治疗近年来国内对HMD的研究重点在肺表面活性物质（PS）的替代疗法。国外自80年代初应用PS治疗HMD以来，欧、美、日本等国以不同类型PS替代治疗严重HMD的报道已逐渐增多（6）。用PS治疗后病死率降低、并发症减少。我国余进等早在1986年建立了家免PS缺乏 Alternative Treatment of Hyaline Membrane Disease in Neonates Domestic research on HMD in recent years has focused on the replacement therapy of pulmonary surfactant (PS). Abroad, since the early 1980s, the treatment of HMD with PS, Europe, the United States, Japan and other countries with different types of PS treatment of HMD reported gradually increased (6). After treatment with PS mortality decreased, complications reduced. As early as 1986, China’s Yu Jin established a PS-free home